Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
City of Hope Medical Center
Jonsson Comprehensive Cancer Center
Children's Oncology Group
Dana-Farber Cancer Institute
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
Case Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Children's Oncology Group
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
University of Maryland, Baltimore
University of Maryland, Baltimore
Sarcoma Alliance for Research through Collaboration
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
National Institutes of Health Clinical Center (CC)
St. Jude Children's Research Hospital
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
NYU Langone Health
City of Hope Medical Center
NYU Langone Health
National Cancer Institute (NCI)
Indiana University
Children's Oncology Group
Children's Oncology Group
City of Hope Medical Center
European Organisation for Research and Treatment of Cancer - EORTC
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group